About
Recharge Biomedical is a clinical practice founded by Dr. Edward Park, a Harvard-trained physician specializing in regenerative medicine and cellular longevity. The clinic focuses on administering exosomes derived from stem cells to enhance tissue repair and slow aging processes. Dr. Park's approach integrates three primary interventions: nanovesicles from placental stem cells for regeneration, TA-65 as a telomerase activator to maintain cellular function, and senolytic agents to eliminate aged cells. The clinic treats a range of conditions including spinal pain, inflammatory bowel disease, sexual health concerns, and cognitive function through targeted exosome delivery methods.
Dr. Park emphasizes personalized medicine grounded in careful listening and individual health history. Each patient receives direct access to Dr. Park via personal cell phone for ongoing communication and feedback. The clinic's treatment philosophy centers on addressing accumulated cellular and tissue damage rather than treating isolated diseases. Services include intrathecal injections for cognitive enhancement, lumbar epidural injections for spinal conditions, intraperitoneal delivery for inflammatory bowel diseases, and sexual health applications.
The practice reflects Dr. Park's 17-year clinical journey with telomerase activation and regenerative medicine. He has built extensive experience with nanovesicle techniques through self-experimentation and treatment of family, friends, and long-standing patients before expanding the practice more broadly. The clinic operates with a commitment to open communication, creative dosing solutions to maximize benefits across multiple problem areas, and documentation of clinical outcomes without reported complications or adverse reactions to date.
Longevity Contribution
- Dr. Park's extensive personal clinical experience with nanovesicles since 2008, including self-experimentation and 17 years of telomerase activation research
- Direct patient access to Dr. Park via personal cell phone for ongoing communication and real-time feedback
- Integrated three-part cellular longevity approach combining nanovesicles, telomerase activation (TA-65), and senolytic agents
- Specialized delivery methods targeting specific tissues and systems, including intrathecal injection for central nervous system access and lumbar epidural injection for spinal conditions